Product correctly added to cart.

Acolbifene
View 3D

Biosynth logo

Acolbifene

CAS: 182167-02-8

Ref. 3D-HHA16702

1mgDiscontinued
5mgDiscontinued
10mgDiscontinued
25mgDiscontinued
50mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
Acolbifene
Synonyms:
  • 2H-1-Benzopyran-7-ol, 3-(4-hydroxyphenyl)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-, (2S)-
  • EM 652
  • 2H-1-Benzopyran-7-ol, 3-(4-hydroxyphenyl)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-, (S)-
  • Sch 57068
  • (2S)-3-(4-Hydroxyphenyl)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-2H-1-benzopyran-7-ol
Description:

Acolbifene is an estrogen receptor antagonist that blocks the effects of estrogen on breast tissue and reduces the risk of developing breast cancer. This drug has been shown to be active in a variety of cancers, including breast cancer, prostate cancer, and lung cancer. Acolbifene binds to the estrogen receptor and prevents the activation of transcription factors necessary for gene expression. It also inhibits angiogenesis and inflammation by binding to enzymes involved in these processes. Acolbifene is used as treatment for autoimmune diseases such as rheumatoid arthritis. The drug has potent antagonistic activity against endogenous estrogens in a model system, but it is not active against other steroid hormones such as progesterone or testosterone.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
457.56 g/mol
Formula:
C29H31NO4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-HHA16702 Acolbifene

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".